Region
Featured experience
Atairos investment in the parent company of the Aston Villa Football Club
We are advising Atairos on the minority investment
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
$100 million investment by consortium in Airbus subsidiary AALTO
We are advising Airbus on the transaction
Haleon $3 billion secondary placing of ordinary shares
The private placement included 700,000,000 ordinary shares
Banco Santander renewal of $25 billion U.S. commercial paper program
We advised Banco Santander on its program renewal
Province of British Columbia $2 billion global bond offering
The investment-grade bonds are due 2028
Sibanye-Stillwater $211.5 million acquisition of Reldan
We are advising Sibanye-Stillwater on the acquisition
WeWork chapter 11 filing
We are advising an ad hoc group of secured noteholders in connection with WeWork’s restructuring
Banco Santander $3.75 billion senior preferred notes
We advised Banco Santander on its investment-grade debt offering
Forbion European Acquisition $138 million combination with enGene
We advised Forbion European Acquisition on its de-SPAC transaction
GSK exclusive license agreement for HS-20089 with Hansoh Pharma
We advised GSK on the transaction
GSK collaboration extension and new data licensing agreement with 23andMe
We advised GSK on the transaction
Oesterreichische Kontrollbank $1 billion notes offering
The 5% notes are due 2026
Roche $7.1 billion acquisition of Telavant and rights to RVT 3101 from Roivant
We are advising Roche on the acquisition